Literature DB >> 8387901

Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failure.

H N Sabbah1, F Hansen-Smith, V G Sharov, T Kono, M Lesch, P J Gengo, R P Steffen, T B Levine, S Goldstein.   

Abstract

BACKGROUND: Whether biochemical and histological abnormalities of skeletal muscle (SM) develop in patients with chronic heart failure (HF) remains controversial. In the present study, dogs with chronic HF were used to examine potential alterations of SM fiber type, fiber size, number of capillaries per fiber (C/F), beta-adrenergic receptor density (Bmax), and fiber ultrastructural integrity. METHODS AND
RESULTS: HF was produced in 17 dogs by sequential intracoronary microembolizations. Biopsies of the lateral head of the triceps muscle were used in all studies. Type I and type II fibers were differentiated by myofibrillar ATPase (pH 9.4 or 4.2). Bmax was assessed by radioligand binding and SM ultrastructure by transmission electron microscopy. Comparisons were made with biopsies obtained from nine control dogs. The percentage of SM type I fibers was reduced in HF dogs compared with control dogs (19 +/- 2% versus 32 +/- 5%) (p < 0.001), whereas the percentage of SM type II fibers was increased (81 +/- 2% versus 68 +/- 5%) (p < 0.001). The change in fiber type composition was not associated with a preferential atrophy or hypertrophy of either fiber type. There was no difference in SM Bmax (198.9 +/- 14.3 versus 186.8 +/- 17.3 fmol/mg protein) or in C/F (5.37 +/- 0.26 versus 5.84 +/- 0.21) between HF dogs and control dogs. No ultrastructural abnormalities were present in SM fibers of HF dogs.
CONCLUSIONS: In dogs with HF, there is a decrease in the relative composition of the slow-twitch type I SM fibers and an increase in fast-twitch type II fibers. The shift in fiber type composition is not associated with preferential atrophy of either fiber type or with a reduction in C/F, beta-adrenergic receptor density, or structural abnormalities of the myofibers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387901     DOI: 10.1161/01.cir.87.5.1729

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  Heart failure: a model of cardiac and skeletal muscle energetic failure.

Authors:  B Mettauer; J Zoll; A Garnier; R Ventura-Clapier
Journal:  Pflugers Arch       Date:  2006-06-10       Impact factor: 3.657

2.  Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis.

Authors:  G Vescovo; F Serafini; L Facchin; P Tenderini; U Carraro; L Dalla Libera; C Catani; G B Ambrosio
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

3.  Improvement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril.

Authors:  F Yamaguchi; K Kawana; K Tanonaka; I Kamano; T Igarashi; E Gen; Y Fujimoto; T Maki; A Sanbe; Y Nasa; S Takeo
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

4.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type.

Authors:  E R Chin; E N Olson; J A Richardson; Q Yang; C Humphries; J M Shelton; H Wu; W Zhu; R Bassel-Duby; R S Williams
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

5.  Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.

Authors:  Sharad Rastogi; Victor G Sharov; Sudhish Mishra; Ramesh C Gupta; Brent Blackburn; Luiz Belardinelli; William C Stanley; Hani N Sabbah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-26       Impact factor: 4.733

6.  Alterations in the calcium homeostasis of skeletal muscle from postmyocardial infarcted rats.

Authors:  Gyula Péter Szigeti; János Almássy; Mónika Sztretye; Beatrix Dienes; László Szabó; Péter Szentesi; Guy Vassort; Sándor Sárközi; László Csernoch; István Jóna
Journal:  Pflugers Arch       Date:  2007-06-09       Impact factor: 3.657

7.  Ventricular remodeling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors.

Authors:  S Goldstein; V G Sharov; J M Cook; H N Sabbah
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

8.  Progression of heart failure: a role for interstitial fibrosis.

Authors:  H N Sabbah; V G Sharov; M Lesch; S Goldstein
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

9.  Estrogen/ERR-α signaling axis is associated with fiber-type conversion of upper airway muscles in patients with obstructive sleep apnea hypopnea syndrome.

Authors:  H H Chen; J Lu; Y F Guan; S J Li; T T Hu; Z S Xie; F Wang; X H Peng; X Liu; X Xu; F P Zhao; B L Yu; X P Li
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

10.  Evaluation of Skeletal Muscle Function and Effects of Early Rehabilitation during Acute Heart Failure: Rationale and Study Design.

Authors:  Kinga Węgrzynowska-Teodorczyk; Agnieszka Siennicka; Krystian Josiak; Robert Zymliński; Monika Kasztura; Waldemar Banasiak; Piotr Ponikowski; Marek Woźniewski
Journal:  Biomed Res Int       Date:  2018-03-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.